clinical trialsDr Kulkarhi , who is a bladder cancer research specialist UHN "views the trials as easily achievable"
The AGM was very revealing. It looks like smooth sailing ahead. UHN is is eager to do the trials. The enrollment will be over subscribed. The trial is happening locally in Toronto..The medical tech is ready to be deployed, .and the endpoint of 1b is safety and tollerability...that's a clear path, a no brainer.The test is immediately revealing...in HD video...and the standart endpoints of 3, 6 mths... the process has a history of an immunity effect.
The process is robust so small sample sizes are acceptable. I think the first test will get the ball rolling, and the second test with stats will be revealing and decisive. By that time there will be an extensive pipeline. This much is known.
There is allways the pesky unknown which haunts us all. Aubrey